Menu

Profile of Dr. Shin-Heng Chiou

My background focuses on both cancer biology and immunology. For my first postdoctoral studies I worked in Dr. Monte Winslow’s laboratory at Stanford University. While most of his lab focuses on lung cancer, I focused my investigations on the tumor microenvironment in pancreatic ductal adenocarcinoma (PDAC) and the impact of microenvironmental cues on metastasis. Within the tumor microenvironment of PDAC, I discovered that hypoxia induces a transient metastatic program in cancer cells (Chiou et al., 2017). I also pioneered CRISPR/Cas9-based methods for PDAC mouse modeling (Chiou et al., 2015; Winters et al., 2017). These tools will help me develop novel approaches to address fundamental questions in PDAC biology. After focusing on cancer cell-intrinsic changes induced by the PDAC tumor microenvironment, I then pursued a short second postdoctoral training with Dr. Mark Davis to learn T cell biology in cancer. The research projects I worked on while at the Davis lab involved understanding the relationships between T cell specificities and the cellular states of tumor-infiltrating T lymphocytes in human non-small cell lung cancer (NSCLC). This effort has led to the identification of highly prevalent T cell clones that are specific to a novel tumor antigen but also cross-react to the antigen from a pathogen. 

image that says give now and support cancer research with link to giving page

 

 

 

 

Logo for ScreenNJ program and link to website

 

 

 

 

Robert Wood Johnson Barnabas Health logo with link to Partners page

 

  

 

 

 

Big Ten Cancer Research Consortium

 

 

 

 

Rutgers Health